This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Enalare Therapeutics Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Thomas Miller - Innovator in Respiratory Treatment
Introduction
Thomas Miller is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of respiratory conditions. His innovative approach focuses on non-opioid agents, which is a crucial area of research given the ongoing concerns regarding opioid use.
Latest Patents
Miller holds a patent titled "Methods of treating respiratory depression modulated by a non-opioid agent." This patent discloses a method of treating respiratory depression by administering an effective amount of a compound selected from a specific formula. This innovative method aims to provide relief to patients in need without the risks associated with opioid medications.
Career Highlights
Throughout his career, Thomas Miller has been associated with Enalare Therapeutics Inc., a company dedicated to advancing therapeutic solutions. His work has been instrumental in developing new treatment methodologies that prioritize patient safety and efficacy.
Collaborations
Miller has collaborated with esteemed colleagues, including Alfred Schweikert and Joseph V Pergolizzi. These partnerships have fostered a collaborative environment that enhances the research and development of innovative treatments.
Conclusion
Thomas Miller's contributions to respiratory treatment through his patent and collaborative efforts highlight his commitment to advancing medical science. His work exemplifies the importance of innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile